|
|
 |
Twinrix®:
Combined Hepatitis A and Hepatitis B Vaccine
On
May 11, 2001, the Food and Drug Administration (FDA) licensed a combined
hepatitis A and B vaccine (Twinrix®) for use in persons aged >18
years. Twinrix is manufactured and distributed by GlaxoSmithKline Biologicals
(Rixensart, Belgium), and is made of the antigenic components used in
Havrix and Engerix-B (GlaxoSmithKline). The antigenic components in Twinrix
have been used routinely in separate single antigen vaccines in the United
States since 1995 and 1989 as hepatitis A and B vaccines, respectively.
Read the entire MMWR
Notice to Readers, 9/21/01, vol. 50 (37); 806-7.
|
|
